Healio

FDA approves Immgolis as first golimumab biosimilar for ulcerative colitis, RA

The FDA has approved golimumab-sldi as the first interchangeable biosimilar to Simponi for ulcerative colitis. Golimumab-sldi ...
WebMD

FDA Expands Approval of Simponi for Use in Pediatric Patients with Ulcerative Colitis

What Is Simponi, and Why Does It Matter? The FDA has approved Simponi (golimumab) for children with moderately to severely active ulcerative colitis (UC) who weigh at least 15 kilograms (33 pounds).
Medical Dialogues

FDA Clears First Interchangeable Golimumab Biosimilars for RA and Ulcerative Colitis

The U.S. Food and Drug Administration has approved the first interchangeable biosimilars of Simponi and Simponi Aria ...
Reuters

FDA approves J&J's Simponi to treat ulcerative colitis

(Reuters) - The Food and Drug Administration has approved Johnson & Johnson's drug Simponi for patients with moderate to severe ulcerative colitis, an inflammatory disease affecting the colon. Simponi ...
Monthly Prescribing Reference

Simponi Aria

SIMPONI ARIA prescription and dosage sizes information for physicians and healthcare professionals. Pharmacology, adverse reactions, warnings and side effects.